Nuclear Medicine and Radio Pharmaceuticals Market Report

Global and Region Nuclear Medicine and Radio Pharmaceuticals Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：144
  • REPORT CODE：GMM940107
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Nuclear Medicine and Radio Pharmaceuticals market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nuclear Medicine and Radio Pharmaceuticalsmarket, defines the market attractiveness level of Nuclear Medicine and Radio Pharmaceuticals market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nuclear Medicine and Radio Pharmaceuticals industry, describes the types of Nuclear Medicine and Radio Pharmaceuticals market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nuclear Medicine and Radio Pharmaceuticals market and the development prospects and opportunities of Nuclear Medicine and Radio Pharmaceuticals industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nuclear Medicine and Radio Pharmaceuticals market in Chapter 13.

    By Player:

    • Toshiba

    • GE Healthcare

    • Biosensors International Group, Ltd

    • Hitachi

    • Carestream

    • Siemens Healthcare

    • Esaote

    • Shimadzu

    • Philips Healthcare

    • TriFoil Imaging

    By Type:

    • Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

    • Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

    By End-User:

    • Diagnostic Applications: SPECT, PET

    • Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nuclear Medicine and Radio Pharmaceuticals Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nuclear Medicine and Radio Pharmaceuticals Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nuclear Medicine and Radio Pharmaceuticals Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nuclear Medicine and Radio Pharmaceuticals Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nuclear Medicine and Radio Pharmaceuticals Market Analysis and Outlook to 2022

    • 7.1 Global Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)

    • 7.2 United States Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)

    • 7.3 Europe Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)

    • 7.4 China Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)

    • 7.5 Japan Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)

    • 7.6 India Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)

    • 7.7 South Korea Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)

    8 Region and Country-wise Nuclear Medicine and Radio Pharmaceuticals Market Analysis and Outlook to 2028

    • 8.1 Global Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)

    • 8.2 United States Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)

    • 8.3 Europe Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)

    • 8.4 China Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)

    • 8.5 Japan Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)

    • 8.6 India Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)

    • 8.7 South Korea Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)

    9 Global Nuclear Medicine and Radio Pharmaceuticals Market Outlook by Types and Applications to 2022

    • 9.1 Global Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Diagnostic Applications: SPECT, PET Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications Consumption and Growth Rate (2017-2022)

    10 Global Nuclear Medicine and Radio Pharmaceuticals Market Outlook by Types and Applications to 2028

    • 10.1 Global Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Diagnostic Applications: SPECT, PET Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nuclear Medicine and Radio Pharmaceuticals Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nuclear Medicine and Radio Pharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nuclear Medicine and Radio Pharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nuclear Medicine and Radio Pharmaceuticals Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nuclear Medicine and Radio Pharmaceuticals Market Competitive Analysis

    • 14.1 Toshiba

      • 14.1.1 Toshiba Company Details

      • 14.1.2 Toshiba Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Toshiba Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • 14.2 GE Healthcare

      • 14.2.1 GE Healthcare Company Details

      • 14.2.2 GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • 14.3 Biosensors International Group, Ltd

      • 14.3.1 Biosensors International Group, Ltd Company Details

      • 14.3.2 Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • 14.4 Hitachi

      • 14.4.1 Hitachi Company Details

      • 14.4.2 Hitachi Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hitachi Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • 14.5 Carestream

      • 14.5.1 Carestream Company Details

      • 14.5.2 Carestream Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Carestream Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • 14.6 Siemens Healthcare

      • 14.6.1 Siemens Healthcare Company Details

      • 14.6.2 Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • 14.7 Esaote

      • 14.7.1 Esaote Company Details

      • 14.7.2 Esaote Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Esaote Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • 14.8 Shimadzu

      • 14.8.1 Shimadzu Company Details

      • 14.8.2 Shimadzu Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Shimadzu Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • 14.9 Philips Healthcare

      • 14.9.1 Philips Healthcare Company Details

      • 14.9.2 Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • 14.10 TriFoil Imaging

      • 14.10.1 TriFoil Imaging Company Details

      • 14.10.2 TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nuclear Medicine and Radio Pharmaceuticals

    • Figure Nuclear Medicine and Radio Pharmaceuticals Picture

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Consumption by Country (2017-2022)

    • Figure United States Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Europe Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Japan Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure India Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure United States Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Applications: SPECT, PET Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Applications: SPECT, PET Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    • Table Toshiba (Foundation Year, Company Profile and etc.)

    • Table Toshiba Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Toshiba Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • Table Biosensors International Group, Ltd (Foundation Year, Company Profile and etc.)

    • Table Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • Table Hitachi (Foundation Year, Company Profile and etc.)

    • Table Hitachi Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hitachi Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • Table Carestream (Foundation Year, Company Profile and etc.)

    • Table Carestream Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Carestream Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • Table Siemens Healthcare (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • Table Esaote (Foundation Year, Company Profile and etc.)

    • Table Esaote Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Esaote Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • Table Shimadzu (Foundation Year, Company Profile and etc.)

    • Table Shimadzu Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shimadzu Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • Table Philips Healthcare (Foundation Year, Company Profile and etc.)

    • Table Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Product and Service

    • Table TriFoil Imaging (Foundation Year, Company Profile and etc.)

    • Table TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US